Friday 29 Mar 2024
By
main news image

This article first appeared in The Edge Malaysia Weekly on January 17, 2022 - January 23, 2022

THE government has set a ceiling price for the commercial sale of two Chinese-made vaccines, namely Sinovac Coronavac and Covilo Sinopharm, which will take effect from Saturday (Jan 15) as prices for vaccines in the private market are high and fluctuating. The wholesale price for a Sinovac vaccine is RM62, while the retail price is RM77. Sinopharm’s wholesale price will now cost no more than RM49, while the retail price is capped at RM61.


AstraZeneca said preliminary data from a trial it conducted on its Covid-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others, including Beta, Delta, Alpha and Gamma, when given as a third booster dose.


South Korea will begin treating coronavirus patients with Pfizer’s antiviral pills on Jan 14, as concern mounts over the spread of the highly contagious Omicron variant. At least 21,000 of the pills, called Paxlovid, arrived on Jan 13 to be distributed to some 280 pharmacies and 90 residential treatment centres.

Save by subscribing to us for your print and/or digital copy.

P/S: The Edge is also available on Apple's AppStore and Androids' Google Play.

      Print
      Text Size
      Share